Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Ethyl Acetate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.82 |
| ▸ | LMNA | P02545 | 1/20 | 0.82 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.82 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | MGAM | O43451 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | SI | P14410 | 1/20 | 0.46 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.46 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.46 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.42 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.42 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 2/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CA9 | Q16790 | 2/20 | 0.39 |
| ▸ | PGR | P06401 | 1/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.39 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethyl Acetate SCHEMBL18921563 | 0.94 | — | — | |
| Pyruvate SCHEMBL22418866 | 0.92 | ALDH1A1 (0.78) | ALDH1A1LMNAHSD17B10TSHRALOX15 | |
| Ethyl Acetate SCHEMBL3525677 | 0.91 | ALDH1A1 (0.88) | ALDH1A1LMNAHSD17B10TSHRALOX15 | |
| Ethyl Acetate SCHEMBL282517 | 0.91 | ALDH1A1 (0.88) | ALDH1A1LMNAHSD17B10TSHRALOX15 | |
| Ethyl Acetate SCHEMBL28294067 | 0.91 | ALDH1A1 (0.88) | ALDH1A1LMNAHSD17B10TSHRALOX15 | |
| Ethyl Acetate SCHEMBL1526797 | 0.91 | ALDH1A1 (0.88) | ALDH1A1LMNAHSD17B10TSHRALOX15 | |
| Ethyl Acetate SCHEMBL15065336 | 0.91 | ALDH1A1 (0.88) | ALDH1A1LMNAHSD17B10TSHRALOX15 | |
| Ethyl Acetate SCHEMBL10598534 | 0.91 | ALDH1A1 (0.88) | ALDH1A1LMNAHSD17B10TSHRALOX15 | |
| Ethyl Acetate SCHEMBL11286195 | 0.91 | ALDH1A1 (0.88) | ALDH1A1LMNAHSD17B10TSHRALOX15 | |
| Ethyl Acetate SCHEMBL5937435 | 0.91 | ALDH1A1 (0.88) | ALDH1A1LMNAHSD17B10TSHRALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118791433-A | Crystal form of oxalate of ilodoline intermediate and preparation method thereof | 上海皓元医药股份有限公司 | 2024-10-18 | — | — | CN | disclosed |
| CN-117024397-A | Amphetamine derivatives, preparation method and application thereof | 江苏恩华药业股份有限公司 | 2023-11-10 | — | — | CN | disclosed |
| EP-4262983-A1 | SOLID FORMS OF BALOXAVIR, SALTS OF BALOXAVIR AND COCRYSTALS OF BALOXAVIR | Synthon B.V. (NL) | 2023-10-25 | — | — | EP | disclosed |
| WO-2022128934-A1 | SOLID FORMS OF BALOXAVIR, SALTS OF BALOXAVIR AND COCRYSTALS OF BALOXAVIR | SYNTHON B.V. (NL) | 2022-06-23 | — | — | WO | disclosed |
| CN-112908558-A | Touch screen conductive silver paste and preparation method and application thereof | 海泰纳鑫科技(成都)有限公司 | 2021-06-04 | — | — | CN | disclosed |
| CN-108473408-A | Ascochlorin derivative and its purposes as AMPK activator | NRL制药股份有限公司 | 2018-08-31 | — | — | CN | disclosed |
| CN-1172997-C | Pastes containing matting and structuring agents and coating mixture containing said pastes | ��Ļ���Ű˾ | 2004-10-27 | — | — | CN | disclosed |
| CN-1361783-A | Thiazoloderivatives and pharmaceutical compositions containing them | KNOLL AG (DE) | 2002-07-31 | — | — | CN | disclosed |
| CN-1300310-A | Pastes containing matting and structuring agents and coating mixture containing said pastes | DU PONT (US) | 2001-06-20 | — | — | CN | disclosed |